The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Aug 2023 16:49

RNS Number : 5191K
Iconic Labs PLC
25 August 2023
 

 

25 August 2023

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

 

Result of AGM

 

Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held at 3pm today, all resolutions were duly passed by way of poll.

At the meeting, inter alia, a resolution was passed which approved the consolidation of the Company's ordinary shares on a 10,000 for 1 basis, such that every 10,000 ordinary shares of £0.00001 each were consolidated into 1 ordinary share of £0.1 in nominal value.

As a result, the Company's existing issued share capital of 46,996,580,000 ordinary shares of £0.00001 was consolidated into 4,699,658 ordinary shares of £0.1, each with one voting right. Admission in respect of such new ordinary shares will become effective and that dealings in those new ordinary shares will commence on 30 August 2023. As a result of the consolidation, the ISIN of the ordinary shares will change from GB00BD060S65 to GB00BRBJ3P08.

The above figure of 4,699,658 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The results of the poll were as follows: 

 

Resolutions

For

%

Against

%

Withheld

1

To receive and adopt the accounts for the financial year ended 30 June 2021.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

2

To receive and adopt the accounts for the financial year ended 30 June 2022.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

3

To re-appoint Norden Audit Limited as Auditors.

6,021,542,347

98.66

81,671,752

1.34

76,346,295

4

To authorise the Directors to determine the remuneration of the Auditors.

6,000,845,301

98.32

102,368,798

1.68

76,346,295

5

To re-appoint Bradley Tyler Taylor as a Director.

6,024,039,929

98.76

75,405,149

1.24

80,115,316

6

To re-appoint David Štýbr as a Director.

6,014,911,904

98.61

84,533,174

1.39

80,115,316

7

To re-appoint Marija Hrebac as a Director.

6,004,365,470

98.44

95,079,608

1.56

80,115,316

8

To re-appoint Emmanuel Blouin as a Director.

5,994,271,904

98.28

105,173,174

1.72

80,115,316

9

Issued ordinary share capital be consolidated and divided into 4,699,658 ordinary shares of £0.1 each.

5,910,559,957

96.84

192,654,142

3.16

76,346,295

10

To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £1,905,217.39.

6,012,800,530

98.52

90,413,569

1.48

76,346,295

Special Resolutions:

11

To empower the Directors to generally allot relevant equity securities under Resolution 10.

6,010,800,530

98.49

92,413,569

1.50

76,346,295

12

To authorise the Directors to make market purchases of own shares.

6,039,251,219

98.95

63,962,880

1.04

76,346,295

 

A vote withheld is not a vote in law and is not counted in the calculation of the percentage of shares voted for or against any resolution.

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMCRUPWGAA
Date   Source Headline
5th Mar 201911:00 amRNSPrice Monitoring Extension
28th Feb 20192:20 pmRNSHolding(s) in Company
26th Feb 20195:44 pmRNSHolding(s) in Company
25th Feb 20198:12 amRNSDirectorate Change
22nd Feb 20195:50 pmRNSPublication of Prospectus
20th Feb 20194:06 pmRNSHolding(s) in Company
1st Feb 201912:35 pmRNSHolding(s) in Company
24th Jan 20193:37 pmRNSHolding(s) in Company
15th Jan 201911:14 amRNSHolding(s) in Company
11th Jan 201912:23 pmRNSHolding(s) in Company
10th Jan 201911:19 amRNSHolding(s) in Company
9th Jan 201912:06 pmRNSHolding(s) in Company
15th Nov 20181:03 pmRNSGM Results
14th Nov 20186:07 pmRNSHolding(s) in Company
6th Nov 20182:18 pmRNSIssue and Allotment of Ordinary Shares
31st Oct 20187:00 amRNS3rd Conversion of Bond
30th Oct 20186:10 pmRNSReplacement - Notice of General Meeting
30th Oct 20184:25 pmRNSNotice of AGM
30th Oct 20182:05 pmRNSSecond Price Monitoring Extn
30th Oct 20182:00 pmRNSPrice Monitoring Extension
30th Oct 20187:00 amRNSWideacademy Restructuring
29th Oct 20184:33 pmRNSHolding(s) in Company
23rd Oct 20188:27 amRNSConversion of Bond
22nd Oct 20183:27 pmRNSConversion of bonds
22nd Oct 20187:00 amRNSSmart Cells Deal
19th Oct 20189:20 amRNSHolding(s) in Company
18th Oct 201812:47 pmRNSBoard Restructuring
17th Oct 20184:48 pmRNSHolding(s) in Company
1st Oct 201811:00 amRNSPrice Monitoring Extension
28th Sep 20183:30 pmRNSHolding(s) in Company
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 201810:40 amRNSNotification of transactions of Directors
27th Sep 20187:10 amRNSInterim Results
27th Sep 20187:00 amRNSFinancing Agreement
30th Jul 20187:00 amRNSCellPlan Launch in Spain
9th Jul 20187:01 amRNSBoard Changes
9th Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20183:00 pmRNSResult of AGM
28th Jun 201810:30 amRNSResult of General Meeting
15th Jun 20187:00 amRNSAlign Research Initiation of Coverage
12th Jun 20186:25 pmRNSProspectus and Notice of General Meeting
11th Jun 20189:00 amRNSLive Market Bookbuild Closes
11th Jun 20187:30 amRNSRestoration Widecells Group Plc
11th Jun 20187:00 amRNSUpdate Regarding Placing and Financial Position
6th Jun 20183:00 pmRNSNotice of AGM
5th Jun 20187:00 amRNSAudited Preliminary Results
21st May 20187:00 amRNSFinal Results Update
10th May 201810:30 amRNSPlacing to Raise £1.47m and Live Market Bookbuild
3rd May 20187:30 amRNSSuspension Widecells Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.